Survey of more than 1,000 consumers demonstrates concerns over permanent synthetic mesh and highlights a strong desire for shared decision-making and surgeon expertise in innovative, more natural options
TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...